tel

Miggo Security Receives Frost & Sullivan’s 2025 Global New Product Innovation Recognition for Advancing Application Security Leadership

The company is redefining application security and AI Runtime Protection through its pioneering Application Detection and Response (ADR) platform for…

2 weeks ago

Patients Taking AUSTEDO XR (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction

Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR®…

2 months ago

Consumers under 40 are skipping life insurance as they delay traditional triggers such as marriage and parenthood

Capgemini Press contact:  Fahd Pasha  Tel.: +1 647 860 3777                          E-mail: Fahd.Pasha@capgemini.com LIMRA Press contact: Catherine Theroux Tel.: +1 (860)…

2 months ago

SciSparc: AutoMaxs Shareholders Approve Merger with SciSparc

TEL AVIV, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage…

3 months ago

Wi-Charge Adds CMO and VP of People to Executive Team Following Series C Funding

Strategic Hires Underscore Momentum as Company Expands Global Commercialization of Long-Range Wireless Power TEL AVIV, Israel, Aug. 7, 2025 /PRNewswire/…

3 months ago

Radware Schedules Conference Call for Its Second Quarter 2025 Earnings

TEL AVIV, Israel, July 02, 2025 (GLOBE NEWSWIRE) -- Radware® (NASDAQ: RDWR), a global leader in application security and delivery…

5 months ago

LightSolver and HLRS Present Joint Research on Optical Computingat ISC High Performance 2025

TEL AVIV, Israel, June 10, 2025 (GLOBE NEWSWIRE) -- LightSolver, inventors of a new laser-based computing paradigm, and HLRS (High-Performance…

5 months ago

Microtech Announces the First U.S. Atrial Microsensor Implantations as Part of its FIH Study

TEL AVIV, Israel, June 9, 2025 /PRNewswire/ -- Microtech, a wholly owned subsidiary of Medinol, is happy to announce the…

5 months ago

ImPact Biotech Announces Treatment of First Patient in Phase 1 Clinical Trial of Padeliporfin VTP in Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma (PDAC)

June 05, 2025 16:31 ET  | Source: ImPact Biotech –  Previously inoperable patient converted to eligible for resection, underwent pancreaticoduodenectomy,…

5 months ago

New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025

More than half of residents with tardive dyskinesia (TD) residing in long-term care (LTC) settings do not receive standard of…

6 months ago